Lucy MacKillop

Dr. Lucy MacKillop

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2018 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
LMLucy MacKillop
Lucy MacKillop
JHJane Elizabeth Hirst
Jane Elizabeth Hirst
KBKaty Jane Bartlett
Katy Jane Bartlett
JBJacqueline Susan Birks
Jacqueline Susan Birks
LCLei Clifton
Lei Clifton
LTLionel Tarassenko
Lionel Tarassenko
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.

9 November 2016 in Journal of Medical Internet Research
Verified
Journal Article
Open access
WMWai-Kit Ming
Wai-Kit Ming
LMLucy MacKillop
Lucy MacKillop
AFAndrew J Farmer
Andrew J Farmer
LLLise Loerup
Lise Loerup
KBKaty Bartlett
Katy Bartlett
JHJane E Hirst
Jane E Hirst
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

1 August 2021 in Hypertension
Verified
Journal Article
Open access
PDF file
JKJamie A. Kitt
Jamie A. Kitt
RFRachael L. Fox
Rachael L. Fox
ACAlexandra E. Cairns
Alexandra E. Cairns
JMJill Mollison
Jill Mollison
HBHolger H. Burchert
Holger H. Burchert
PLPaul Leeson
Paul Leeson
Women with hypertensive pregnancies are 4× more likely to develop chronic hypertension. Previously, we showed a short period of blood pressure (BP) self-management following hypertensive pregnancy resulted in persistently lower BP after 6 months. We now report the impact on long-term BP control. Women who participated in the postpartum randomized controlled trial, SNAP-HT (Self-Management of Postnatal Hypertension; NCT02333240), were invited for 24-hour ambulatory and clinic BP measures. Height and weight were measured by calibrated scales and standardized tape measures, activity by 7-day wrist-worn accelerometer, and dietary factors assessed by questionnaire. Sixty-one of 70 eligible women were followed up 3.6±0.4 years after their original pregnancy. Twenty-four–hour diastolic BP was 7.0 mm Hg lower in those originally randomized to postpartum BP self-management instead of usual care. This difference remained significant after adjustment for either BP at the time of delivery (−7.4 mm Hg [95% CI, −10.7 to −4.2]; P <0.001) or pregnancy booking BP (−6.9 mm Hg [95% CI, −10.3 to −3.6]; P <0.001). Adjustment for current salt intake, age, body mass index, waist-to-hip ratio, arm circumference, parity, alcohol intake, and physical activity had no effect on this difference. Reductions in diastolic BP at 6 months, following self-management of BP postpartum, are maintained 3.6 years later as measured by lower 24-hour diastolic BP. Interventions to optimize BP control during the puerperium in women with hypertensive pregnancies improve BP in the longer term, in a cohort at increased risk of developing chronic hypertension and major adverse cardiovascular events. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02333240.

11 September 2019 in BMC Medicine
Verified
Journal Article
Open access
PDF file
LLLise Loerup
Lise Loerup
RPRebecca M. Pullon
Rebecca M. Pullon
JBJacqueline Susan Birks
Jacqueline Susan Birks
SFSusannah Fleming
Susannah Fleming
LMLucy MacKillop
Lucy MacKillop
PWPeter J. Watkinson
Peter J. Watkinson
Background: Current reference ranges for blood pressure and heart rate throughout pregnancy have a poor evidence base. Methods: This is a systematic review and meta-analysis. We included studies measuring blood pressure or heart rate from healthy pregnant women within defined gestational periods of 16 weeks or less. We analysed systolic blood pressure, diastolic blood pressure and heart rate by gestational age. We assessed effects of measurement year and method. Results: We included 39 studies undertaken in 1967–2017, containing 124,349 systolic measurements from 36,239 women, 124,291 diastolic measurements from 36,181 women and 10,948 heart rate measurements from 8317 women. Mean (95% CI) systolic blood pressure was lowest at 10 weeks gestation, 110.4 (108.5, 112.3) mmHg, rising to 116.0 (113.6, 118.4) mmHg at 40 weeks, mean (95% CI) change 5.6 (4.0, 7.2) mmHg. Mean (95% CI) diastolic blood pressure was lowest at 21 weeks gestation, 65.9 (64.2, 67.7) mmHg; rising to 72.8 (71.0, 74.6) mmHg at 40 weeks, mean (95% CI) change 6.9 (6.2, 7.5) mmHg. Mean (95% CI) heart rate rose from 79.3 (75.5, 83.1) beats/min at 10 weeks to 86.9 (82.2, 91.6) beats/min at 40 weeks gestation, mean (95% CI) change 7.6 (1.8, 13.4) beats/min. Studies using manual measurement reported higher diastolic blood pressures than studies using automated measurement, mean (95 CI) difference 4.9 (0.8, 8.9) mmHg. Diastolic blood pressure increased by 0.26 (95% CI 0.10–0.43) mmHg/year. Including only higher-quality studies had little effect on findings, with heterogeneity remaining high (I2 statistic > 50%). Conclusions: Significant gestational blood pressure and heart rate changes occur that should be taken into account when assessing pregnant women. Commonly taught substantial decreases in blood pressure mid-pregnancy were not seen and heart rate increases were lower than previously thought. Manual and automated blood pressure measurement cannot be used interchangeably. Increases in diastolic blood pressure over the last half-century and differences between published studies show contemporary data are required to define current normal ranges. Study registration: PROSPERO CRD42014009673

13 February 2024 in Circulation
Verified
Journal Article
Open access
JKJamie Kitt
Jamie Kitt
SKSamuel Krasner
Samuel Krasner
LBLogan Barr
Logan Barr
AFAnnabelle Frost
Annabelle Frost
KTKatherine Tucker
Katherine Tucker
PLPaul Leeson
Paul Leeson
BACKGROUND: Hypertensive pregnancy disorders are associated with adverse cardiac remodeling, which can fail to reverse in the postpartum period in some women. The Physician-Optimized Postpartum Hypertension Treatment trial demonstrated that improved blood pressure control while the cardiovascular system recovers postpartum associates with persistently reduced blood pressure. We now report the effect on cardiac remodeling. METHODS: In this prospective, randomized, open-label, blinded end point trial, in a single UK hospital, 220 women were randomly assigned 1:1 to self-monitoring with research physician-optimized antihypertensive titration or usual postnatal care from a primary care physician and midwife. Participants were 18 years of age or older, with preeclampsia or gestational hypertension, requiring antihypertensives on hospital discharge postnatally. Prespecified secondary cardiac imaging outcomes were recorded by echocardiography around delivery, and again at blood pressure primary outcome assessment, around 9 months postpartum, when cardiovascular magnetic resonance was also performed. RESULTS: A total of 187 women (101 intervention; 86 usual care) underwent echocardiography at baseline and follow-up, at a mean 258±14.6 days postpartum, of which 174 (93 intervention; 81 usual care) also had cardiovascular magnetic resonance at follow-up. Relative wall thickness by echocardiography was 0.06 (95% CI, 0.07–0.05; P <0.001) lower in the intervention group between baseline and follow-up, and cardiovascular magnetic resonance at follow-up demonstrated a lower left ventricular mass (–6.37 g/m 2 ; 95% CI, –7.99 to –4.74; P <0.001), end-diastolic volume (–3.87 mL/m 2 ; 95% CI, –6.77 to –0.98; P =0.009), and end-systolic volume (–3.25 mL/m 2 ; 95% CI, 4.87 to –1.63; P <0.001) and higher left and right ventricular ejection fraction by 2.6% (95% CI, 1.3–3.9; P <0.001) and 2.8% (95% CI, 1.4–4.1; P <0.001), respectively. Echocardiography-assessed left ventricular diastolic function demonstrated a mean difference in average E/E’ of 0.52 (95% CI, –0.97 to –0.07; P =0.024) and a reduction in left atrial volumes of –4.33 mL/m 2 (95% CI, –5.52 to –3.21; P <0.001) between baseline and follow-up when adjusted for baseline differences in measures. CONCLUSIONS: Short-term postnatal optimization of blood pressure control after hypertensive pregnancy, through self-monitoring and physician-guided antihypertensive titration, associates with long-term changes in cardiovascular structure and function, in a pattern associated with more favorable cardiovascular outcomes. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04273854.

19 December 2017 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
LHLisa Hinton
Lisa Hinton
KTKatherine L. Tucker
Katherine L. Tucker
SGSheila Greenfield
Sheila Greenfield
JHJames A. Hodgkinson
James A. Hodgkinson
LMLucy MacKillop
Lucy MacKillop
RMRichard J McManus
Richard J McManus
Hypertensive disorders in pregnancy are a leading cause of maternal and fetal morbidity worldwide. Raised blood pressure (BP) affects 10% of pregnancies worldwide, of which almost half develop pre-eclampsia. The proportion of pregnant women who have risk factors for pre-eclampsia (such as pre-existing hypertension, obesity and advanced maternal age) is increasing. Pre-eclampsia can manifest itself before women experience symptoms and can develop between antenatal visits. Incentives to improve early detection of gestational hypertensive disorders are therefore strong and self-monitoring of blood pressure (SMBP) in pregnancy might be one means to achieve this, whilst improving women’s involvement in antenatal care. The Blood Pressure Self-Monitoring in Pregnancy (BuMP) study aimed to evaluate the feasibility and acceptability of SMBP in pregnancy. To understand women’s experiences of SMBP during pregnancy, we undertook a qualitative study embedded within the BuMP observational feasibility study. Women who were at higher risk of developing hypertension and/or pre-eclampsia were invited to take part in a study using SMBP and also invited to take part in an interview. Semi-structured interviews were conducted at the women’s homes in Oxfordshire and Birmingham with women who were self-monitoring their BP as part of the BuMP feasibility study in 2014. Interviews were conducted by a qualitative researcher and transcribed verbatim. A framework approach was used for analysis. Fifteen women agreed to be interviewed. Respondents reported general willingness to engage with monitoring their own BP, feeling that it could reduce anxiety around their health during pregnancy, particularly if they had previous experience of raised BP or pre-eclampsia. They felt able to incorporate self-monitoring into their weekly routines, although this was harder post-partum. Self-monitoring of BP made them more aware of the risks of hypertension and pre-eclampsia in pregnancy. Feelings of reassurance and empowerment were commonly reported by the women in our sample. SMBP in pregnancy was both acceptable and feasible to women in this small pilot study.